{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:25:25Z","timestamp":1790774725198,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2024J040"],"award-info":[{"award-number":["2024J040"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970735"],"award-info":[{"award-number":["81970735"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cyto.2025.157058","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:52:39Z","timestamp":1760694759000},"page":"157058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Unveiling IL-41: A novel biomarker for polymyositis and dermatomyositis diagnosis"],"prefix":"10.1016","volume":"196","author":[{"given":"Zhi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiudi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cyto.2025.157058_bb0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of myositis","volume":"14","author":"Lundberg","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157058_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117443","article-title":"Polymyositis and dermatomyositis biomarkers","volume":"547","author":"Xu","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.cyto.2025.157058_bb0015","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.cyto.2025.157058_bb0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","article-title":"Review: An update on inflammatory and autoimmune myopathies","volume":"37","author":"Dalakas","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"4","key":"10.1016\/j.cyto.2025.157058_bb0025","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0889-857X(02)00030-3","article-title":"Muscle biopsy findings in inflammatory myopathies","volume":"28","author":"Dalakas","year":"2002","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"9388","key":"10.1016\/j.cyto.2025.157058_bb0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cyto.2025.157058_bb0035","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2025.157058_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2019.100018","article-title":"Polymyositis and dermatomyositis - challenges in diagnosis and management","volume":"2","author":"Yang","year":"2019","journal-title":"J. Transl. Autoimmun."},{"issue":"6","key":"10.1016\/j.cyto.2025.157058_bb0045","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"De Paepe","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2025.157058_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2008.02.005","article-title":"IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts","volume":"196","author":"Marino","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.cyto.2025.157058_bb0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11926-012-0242-x","article-title":"Interleukin-17 in inflammatory myopathies","volume":"14","author":"Tournadre","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"issue":"10","key":"10.1016\/j.cyto.2025.157058_bb0060","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/rheumatology\/keq196","article-title":"Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"17","key":"10.1016\/j.cyto.2025.157058_bb0065","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1242\/dev.137075","article-title":"Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination","volume":"143","author":"Yu","year":"2016","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.cyto.2025.157058_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/nu13092950","article-title":"Maslinic acid attenuates denervation-induced loss of skeletal muscle mass and strength","volume":"13","author":"Yamauchi","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cyto.2025.157058_bb0075","first-page":"C38","article-title":"FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70","volume":"298","author":"Senf","year":"2010","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"1","key":"10.1016\/j.cyto.2025.157058_bb0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2011.09.027","article-title":"Cometin is a novel neurotrophic factor that promotes neurite outgrowth and neuroblast migration in vitro and supports survival of spiral ganglion neurons in vivo","volume":"233","author":"J\u00f8rgensen","year":"2012","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.cyto.2025.157058_bb0085","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41401-020-00529-9","article-title":"Involvement of the secreted protein Metrnl in human diseases","volume":"41","author":"Miao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cyto.2025.157058_bb0090","doi-asserted-by":"crossref","first-page":"1098570","DOI":"10.3389\/fimmu.2023.1098570","article-title":"Meteorin-like\/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: a comprehensive review of preclinical and clinical studies","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.157058_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114118","article-title":"Exercise induced meteorin-like protects chondrocytes against inflammation and pyroptosis in osteoarthritis by inhibiting PI3K\/Akt\/NF-\u03baB and NLRP3\/caspase-1\/GSDMD signaling","volume":"158","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.cyto.2025.157058_bb0100","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s42255-020-0184-y","article-title":"Meteorin-like facilitates skeletal muscle repair through a Stat3\/IGF-1 mechanism","volume":"2","author":"Baht","year":"2020","journal-title":"Nat. Metab."},{"issue":"12","key":"10.1016\/j.cyto.2025.157058_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123480","article-title":"Exercise inhibits NLRP3 Inflammasome activation in obese mice via the anti-inflammatory effect of Meteorin-like","volume":"10","author":"Javaid","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2025.157058_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.938341","article-title":"Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile","volume":"13","author":"Ding","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.cyto.2025.157058_bb0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jcmm.13915","article-title":"Serum Metrnl is associated with the presence and severity of coronary artery disease","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cyto.2025.157058_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cca.2022.11.021","article-title":"Increased serum IL-41 is associated with disease activity in rheumatoid arthritis","volume":"538","author":"Gong","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cyto.2025.157058_bb0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/all.16150","article-title":"Meteorin-like protein\/METRNL\/Interleukin-41 ameliorates atopic dermatitis-like inflammation","volume":"80","author":"Huang","year":"2025","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.cyto.2025.157058_bb0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.cyto.2025.157058_bb0135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cyto.2025.157058_bb0140","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/BOR.0000000000000744","article-title":"Cytokines and inflammatory mediators as promising markers of polymyositis\/dermatomyositis","volume":"32","author":"Cerezo","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157058_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101747","article-title":"Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP\/PKA\/SIRT1 pathway","volume":"37","author":"Hu","year":"2020","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.cyto.2025.157058_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0147-5","article-title":"METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPAR\u03b4-dependent pathways in skeletal muscle of mice","volume":"50","author":"Jung","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.cyto.2025.157058_bb0155","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2025.157058_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cyto.2025.157058_bb0165","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10067-022-06425-3","article-title":"Circulating VEGF-A, TNF-alpha, CCL2, IL-6, and IFN-gamma as biomarkers of cancer in cancer-associated anti-TIF1-gamma antibody-positive dermatomyositis","volume":"42","author":"Li","year":"2023","journal-title":"Clin. Rheumatol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625002054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625002054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:59:41Z","timestamp":1773179981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625002054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S1043466625002054"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157058","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling IL-41: A novel biomarker for polymyositis and dermatomyositis diagnosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157058"}}